Press Release Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T Tempest Therapeutics · Jul 21
Press Release R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis R1 Therapeutics · Jul 21
Press Release Talisker Reports Mustang Underground Face Sample Results and Defines a 127 metre Strike Length High-grade Shoot Averaging 22 g/t on the 1045 Level including 610 g/t over 0.51 of a metre Talisker Resources Ltd. · Jul 21
Press Release PBS Biotech Wins 2026 Cell Products Development of the Year Award PBS Biotech Inc. · Jul 21
Press Release Denodo Honors Outstanding Customer Implementations Across 10 Key Industry Verticals Denodo Technologies Inc. (“Denodo”) · Jul 21
Press Release Nektar Therapeutics Announces Start of Phase 3 ZENITH AD Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis Nektar Therapeutics · Jul 21
Press Release Altesa BioSciences Welcomes Seasoned Biotech Leader Brett Haumann, MBBCh, MBA as Chief Executive Officer Altesa Biosciences Inc. · Jul 21
Press Release Imagine360 and Health Rosetta Launch Integrated Health Plan for Employers Facing Record Cost Increases Imagine360 · Jul 21